The diagnostics company Virogates wants to bring in more than DKK 60 million (USD 9.4 million) on the stock exchange, which will be used to boost sales of the company's blood test. The goal is to have 40 paying customers in two years says CEO.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.